The Estimation of Prevalence, Incidence, and Residual Risk of Transfusion-Transmitted Human Hepatitis B Infection from Blood Donated at the Anhui Blood Center, China, from 2009 to 2011

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Li, Wuping ^a,b   Gao, Zhan ^b   Yang, Chunhui ^b   Li, Jiahu ^c   Li, Ling ^c   Lv, Rong ^c   Liu, Zhong ^b,c  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Anhui Blood Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; CHINA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS ELISA KIT; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RAPID TEST; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD TRANSFUSION; CHINA; COMMUNITY HEALTH CENTERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84884141377     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073472     Document Type: Article

References (23)

1. Alter HJ, Houghton M, (2000) Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 6: 1082-1086. doi:10.1038/80394. PubMed: 11017126.
2. Candotti D, Allain JP, (2009) Transfusion-transmitted hepatitis B virus infection. J Hepatol 51: 798-809. doi:10.1016/j.jhep.2009.05.020. PubMed: 19615780.
3. Niederhauser C, (2011) Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2: 91-102. PubMed: 22287868.
4. Dodd RY, (2004) Current safety of the blood supply in the United States. Int J Hematol 80: 301-305. doi:10.1532/IJH97.04123. PubMed: 15615252.
5. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334: 1685-1690. doi:10.1056/NEJM199606273342601. PubMed: 8637512.
6. Allain JP, (2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86: 83-91. doi:10.1111/j.0042-9007.2004.00406.x. PubMed: 15023176.
7. Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, et al. (2003) High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 112: 145-151. doi:10.1016/S0166-0934(03)00215-5. PubMed: 12951223.
8. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557. doi:10.1016/j.vaccine.2009.08.048. PubMed: 19729084.
9. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 200: 39-47. doi:10.1086/605035. PubMed: 19469708.
10. Li C, Xiao X, Yin H, He M, Li J, et al. (2012) Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010. J Transl Med, 10: 176-. PubMed: 22929614.
11. Liu Y, Li P, Li C, Zhou J, Wu C, et al. (2010) Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J 7: 193. doi:10.1186/1743-422X-7-193. PubMed: 20718994.
12. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, et al. (2009) Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 49: 1609-1620. doi:10.1111/j.1537-2995.2009.02195.x. PubMed: 19413732.
13. Wang J, Liu J, Yao F, Wen G, Li J, et al. (2012) Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors. Transfusion, 53: 1240-9. PubMed: 23113801.
14. Ren FR, Wang JX, Huang Y, Yao FZ, Lv YL, et al. (2011) Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion 51: 2588-2595. doi:10.1111/j.1537-2995.2011.03215.x. PubMed: 21682731.
15. Kleinman SH, Busch MP, (2006) Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol Off Publ Pan American Society For Clinical Virology 36 (Suppl 1):: S23-S29. doi:10.1016/S1386-6532(06)80078-8. PubMed: 16831689.
16. Dodd RY, Orton SL, Notari EPt, Stramer SL (2002) Viral marker rates among blood donors before and after the terrorist attacks on the United States on September 11 2001. Transfusion 42: 1240-1241.
17. (1989) SAS/STAT user's guide, version 6. 4th ed. Cary (NC): SAS Institute.
18. (2000) Crystal ball software 2000.2 user manual. Denver (CO): Decisioneering, Inc.
19. Li C, Xiao X, Yin H, He M, Li J, et al. (2012) Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010. J Transl Med 10: 176. doi:10.1186/1479-5876-10-176. PubMed: 22929614.
20. Glynn SA, Schreiber GB, Busch MP, Kleinman SH, Williams AE, et al. (1998) Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 38: 350-358. doi:10.1046/j.1537-2995.1998.38498257373.x. PubMed: 9595017.
21. Seed CR, Kiely P, Keller AJ, (2005) Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Intern Med J 35: 592-598. doi:10.1111/j.1445-5994.2005.00926.x. PubMed: 16207258.
22. Shang G, Seed CR, Wang F, Nie D, Farrugia A, (2007) Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 47: 529-539. doi:10.1111/j.1537-2995.2006.01146.x. PubMed: 17319836.
23. Dodd RY, Notari EPt, Stramer SL, (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42: 975-979.